Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B.
J Formos Med Assoc
; 120(9): 1676-1685, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-33339708
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
/
Hepatitis B e Antigens
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Formos Med Assoc
Journal subject:
MEDICINA
Year:
2021
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Singapur